An epigenetic regulator-related score (EpiScore) predicts survival in patients with diffuse large B cell lymphoma and identifies patients who may benefit from epigenetic therapy

Diffuse large B-cell lymphoma (DLBCL) is the most common form of lymphoma and shows considerable clinical and biological heterogeneity. Much research is currently focused on the identification of prognostic markers for more specific patients’ risk stratification and on the development of therapeutic...

Descripción completa

Detalles Bibliográficos
Autores principales: Szablewski, Vanessa, Bret, Caroline, Kassambara, Alboukadel, Devin, Julie, Cartron, Guillaume, Costes-Martineau, Valérie, Moreaux, Jérôme
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5922379/
https://www.ncbi.nlm.nih.gov/pubmed/29721185
http://dx.doi.org/10.18632/oncotarget.24901

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5922379/
https://www.ncbi.nlm.nih.gov/pubmed/29721185
http://dx.doi.org/10.18632/oncotarget.24901

Ejemplares similares